Lotus Bio-Technology Development

Lotus Bio-Technology Development EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lotus Bio-Technology Development (LBTD) as of Oct 20, 2026 is -19,600.00 USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -18,700.00 USD — a change of 4.81% (lower).

EBITDA

-19,600.00USD

YoY

4.81%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lotus Bio-Technology Development is 2017 -19,600.00 USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lotus Bio-Technology Development was 2016 -18,700.00 USD. It decreases by 4.81% lower compared to the previous year.

The Lotus Bio-Technology Development EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2014
-16,000.00 USD
Jan 1, 2015
-18,700.00 USD
Jan 1, 2016
-18,700.00 USD
Jan 1, 2017
-19,600.00 USD
The Lotus Bio-Technology Development EBITDA history
YEAREBITDAYoY
-19,600.00USD+4.81%
-18,700.00USD0.00%
-18,700.00USD+16.87%
-16,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Lotus Bio-Technology Development Stock analysis

What does Lotus Bio-Technology Development do? Lotus Bio-Technology Development Corp, listed in 2013, operates in Hong Kong and specializes in refining organic materials to produce natural consumer products. The company is exploring opportunities in organic farming and growth in China, focusing on organizational planning and business development. Currently in the start-up phase with no revenue generated, it is developing its business plan and website. Lotus Bio-Technology Development is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lotus Bio-Technology Development stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lotus Bio-Technology Development is -19,600.00 USD in 2017.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lotus Bio-Technology Development changed from -18,700.00 USD to -19,600.00 USD, representing a 4.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Lotus Bio-Technology Development since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Lotus Bio-Technology Development historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Lotus Bio-Technology Development

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Lotus Bio-Technology Development